FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LENACAPAVIR SODIUM
异名/同义词1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE-1-ACETAMIDE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-5,5-DIFLUORO-3B,4,4A,5-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, SODIUM SALT (1:1), (3BS,4AR)-
GS-6207-02
GS-HIV SODIUM
LENACAPAVIR SODIUM
LENACAPAVIR SODIUM [USAN]
LENACAPAVIR SODIUM [WHO-DD]
N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO-3-(TRIFLUOROMETHYL)-3B,4,4A,5-TETRAHYDRO1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOL-1-YL)ACETAMIDE, SODIUM SALT (1:1)
SUNLENCA
YEZTUGO
CAS登记号2283356-12-5
物质唯一标识(Unique Ingredient Identifier)BDT58WJ9WE
分子式BDT58WJ9WE
国际化合物标识(International Chemical Identifier,InChI)C39H31ClF10N7O5S2.Na
SMILESSSXPGMNGIORJAQ-PZNXWHLTSA-M
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型C(Cn1nc(c2c1C([C@]3([C@@]2(C3)[H])[H])(F)F)C(F)(F)F)(=O)N[C@@H](Cc4cc(cc(c4)F)F)c5c(ccc(n5)C#CC(C)(S(=O)(=O)C)C)-c6ccc(c7c(nn(c67)CC(F)(F)F)[N-]S(=O)(=O)C)Cl.[Na+] / INGREDIENT SUBSTANCE
关联数据
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System